Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNTech SE

100.31
+1.921.95%
Post-market: 99.99-0.3200-0.32%19:01 EDT
Volume:1.55M
Turnover:154.52M
Market Cap:24.05B
PE:-34.98
High:101.08
Open:100.13
Low:97.82
Close:98.39
Loading ...

GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs

NewMediaWire
·
05 Feb

Commentary: COVID-19 changed Singapore. Have we changed enough?

CNA
·
05 Feb

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

Dow Jones
·
05 Feb

RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.

Blockhead
·
05 Feb

Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable?

Blockhead
·
04 Feb

Pfizer Q4 Earnings: Revenue And EPS Beat, Seagen And COVID-19 Products Show Strength, Issues Strong FY25 Outlook

Benzinga
·
04 Feb

GeoVax to Showcase Advancements in Vaccines & Immunotherapies at the 2025 BIO CEO & Investor Conference

NewMediaWire
·
04 Feb

Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance

Business Wire
·
04 Feb

Invivyd’s Promising Developments in COVID-19 Therapeutics Support Buy Rating

TIPRANKS
·
04 Feb

Bank of America Securities Reaffirms Their Buy Rating on BioNTech SE (BNTX)

TIPRANKS
·
04 Feb

Invivyd Shares Soar Premarket After Tripling Monday Following Initial Results From COVID-19 Vaccination Alternative

MT Newswires Live
·
04 Feb

2 Ultra-High-Yield Dividend Stocks That Are No-Brainer Buys in February

Motley Fool
·
04 Feb

GeoVax Announces Strategic Integration of AI in Support of President Trump's Stargate Initiative

NewMediaWire
·
03 Feb

Invivyd Announces Positive Phase 1/2 Clinical Data for VYD2311, a Monoclonal Antibody Designed to be a Superior Alternative to COVID-19 Vaccination for the Broad Population

GlobeNewswire
·
03 Feb

Biontech Completes Acquisition Of Biotheus

Reuters
·
03 Feb

Invivyd Announces Preliminary Fourth Quarter 2024 Financial Results, Strong Revenue Growth, and Reiterates Goal of Near-Term Profitability

GlobeNewswire
·
03 Feb